"MUST READ" Alright $IMMB Investors and Future Investors

New Post Public Reply Private Reply Replies (0) Message Board
MoneyMaker

"MUST READ" Alright $IMMB Investors and Future Investors here is why I just posted a world of info on HIV/AIDS, To show everyone we are sitting on an ABSOLUTE LIFE CHANGER.

Amazing Website >> http://www.immunotechlab.com/


As you can see the market here is wide open for growth and by 2018 will consist of a $21 Billion Industry with a steady growth of 7% per annum. More IMPORTANTLY we are in an transition period where MANY current PATENTS will EXPIRE, leaving the door wide open for IMMB! 

Why is that important to IMMB, there is simply room for Competitors and definite interest for MERGERS/ACQUISITIONS of smaller cap companies. Something in this economy that is happening everyday.

Well here is my take as to WHY you should BUY IMMB.... 

IMMB currently carries a HV/AIDS PATENT valued at over $5 Million >> http://imagehost.vendio.com/a/8709739/view/Patent.png

So we are in the market. Now we need a game plan, well Dr. Harry Zhabilov worked his ass off for many years using his amazing scientific skills to create a patent... IMMB then realizes they can tap into a Billion Dollar Market with his Patents which for the record we have not one but 4 Patents. ...Mr.Zhabilov is an amazing Doctor....but he can't do it on his own so on October of 2012 he makes an even more Brilliant move than his Patent Creation, HE SIGNS a contract with Mr. Bo Linton and appointed him to be part of the Board of Directors .
Well for the people who don't know BO LINTON he has a habit of taking the companies he is involved with to the BIG BOARDS NYSE/NASDAQ)...His last one being MAGNEGAS whom just recently rang the closing bell!

As of February/2013 IMMB made another BIG move, they appointed Mr. Valentin Dimitrov to the board of directors of the company. Mr. Dimitrov is a CEO of M.T. Rose Corporation also Mr. Dimitrov is one of the owners of the second largest chemical plant in Bulgaria, Europe.

So now we have a growing Board with TOP notch Members whom carry HUGE connections.

Still with me, well on November 2012 a HUGE NEWS RELEASE Link Provided >> http://www.otcmarkets.com/stock/IMMB/news
Immunotech Laboratories Inc. Announces Breakthrough Results for HIV and AIDS Treatment for Terminal Salvage Patients

Followed by a much BIGGER News RELEASE JAN/2013 Link Provided >> http://www.otcmarkets.com/stock/IMMB/news
Immunotech Laboratories Announces LOI With International Bio-Tech Partner For USA Clinical Trials Funding Of Patented HIV Medicines 

Which in turn led to THE BIGGEST ONE TO DATE FEB/2013 Link Provided >> Immunotech Laboratories (IMMB) Patented "IPF" Technology A Serious Contender In The Race For HIV & Cancer Cures

If you are still with me you are now adding everything up and saying to yourself HOLY SH*T, We are OFFICIALLY INVOLVED in THAT COVETED BILLION DOLLAR MARKET....and you should be saying IMMB is the MOST UNDERVALUED MEDICAL SCIENCE COMPANY in the OTC soon to be NASDAQ and or NYSE... 


From the last PR and in the words of MR.BO LINTON (read BOLD)>>
Mr. Linton further commented the company recently received an initial inquiry for a significant order of the company's patented HIV vaccine by an International associate for use as an "Experimental Drug". If confirmed the initial order would be in excess of several Million Dollars. This would expand the company's operations from Research & Development to a Bio-Pharma manufacturing company . In Africa, where approved experimental treatments are permitted, there are approximately 30 Million HIV/AIDS patients alone.

Now that you are seeing what I am seeing I will show you the KICKER >> 

CURRENT SHARE STRUCTURE 
OUTSTANDING SHARES 60,500,000 give or take a handful
FLOAT 1 MILLION YES, MILLION (give or take a handful)CONFIRMED Jan.31/2013 in video interview with MR. LINTON (link provided ) >> http://www.otcmarkets.com/stock/IMMB/news
AUTHORIZED 150,000,000

Want More, I have more >>
INSIDERS HOLDINGS 98% of O/S Here is the PROOF >> 
Name of Shareholder Number of Shares
Harry Zhabilov 24,895,646 41.11
Ara Ghanime 24,895,646 41.11
Dow Jones Link 2,773,500 4.58
Allie Chang 600,000 1.0
Paul Felizian 600,000 1.0
Lord George Equities 5,400,000 9.0
Joseph Pittera 250,000 0.41
Harout Tovmasyan 151,000 0.25
Elie Sakayan 50,000 0.08
Hagop Parseghian 600,000 1.0
Others 339,896 0.46

So there you have it!

PS since last Wednesday in case you missed it we have seen LESS than 400,000 Shares TRADED or for the most part BOUGHT and we are up from .06 to .35 with MAJOR NEWS PENDING....with that said we have seen MAJOR BIDS UNTOUCHED where investors could have taken HUGE PERCENTAGE GAINS and SIMPLY REFUSED to knowing where IMMB is heading SHORT TERM and or LONG TERM! 

Good LUCK and REMEMBER only use this as a reference an never spend more than you are willing to lose.

Your Friend Cheeky!

PSS there is more to IMMB than HIV/AIDS Please go to WEBSITE and absorb as much as you can, They are diversified to say the least...link provided above!

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Rise Treatment Center Launches in Vegas for Teens

Updated Category News Views 6

Las Vegas Debuts Rise Adolescent Treatment Center Imagine being a parent in Las Vegas, staring at the daunting task of finding genuine help for your teenage kid just entering those rebellious years. The choices usually feel sparse and lacking. But on August 13, 2026, a shimmer of hope illuminated the landscape with the opening of Rise Adolescent Treatment Center. It’s a...

Continue Reading
Dr. David Lifschutz Honored for Psychiatry Innovation

Updated Category News Views 7

Recognizing a Legacy in Mental Wellness Under the glare of recognition's spotlight, Dr. David H. Lifschutz steps into an exclusive circle of elite professionals. He's been acknowledged as a Pinnacle Lifetime Member by The Inner Circle for his remarkable contributions to psychiatry and mental health care. This ain't just any pat on the back. It's a badge of honor stitched...

Continue Reading
Starr Conspiracy Unveils AI Tool for B2B Tech Firms

Updated Category News Views 6

AI-Driven Insight in Minutes: A Game Changer for B2B Hold onto your hats, because The Starr Conspiracy just lit a fire in the B2B tech world with its latest offering—Battle Card Builder. This free tool cranks out competitive intelligence in no time, literally about four minutes. Geared specifically for B2B tech marketing and sales teams, it combines decades of know-how...

Continue Reading
NSF Backs New Space Projects: Cooling & Drug Delivery

Updated Category News Views 7

You know, every time we think we're at the edge of current science, space reminds us how little we actually know. From the International Space Station up there in low Earth orbit, fresh experiments are kicking off to change what we understand about electronics cooling and drug delivery. It's a classic scenario of reaching for the stars to help us out back here on Earth....

Continue Reading
Unicycive's Legal Turmoil: Opportunity for Investor Action

Updated Category News Views 5

Unicycive's Legal Headache: What's Brewing? Here we go again, folks. If you're holding shares of Unicycive Therapeutics, Inc. (UNCY), buckle up because it's looking like a storm's on the horizon. The Law Offices of Howard G. Smith have dropped the news that shareholders can step up to lead a securities fraud class action lawsuit against the company. That chance to be part...

Continue Reading
Brands Must Choose: Cost or Value Leadership?

Updated Category News Views 6

Navigating the Business Jungle: Strategic Choices Unveiled If you've ever found yourself tangled in a web of corporate doublespeak, then you'll nod along with this: all those lofty brand management strategies often boil down to a fight over dollars or dizzying customer satisfaction. What's the winning play? According to Info-Tech Research Group, it's about firmly standing...

Continue Reading
illycaffè's B Corp™ Recertification Reflects Bold Commitment

Updated Category News Views 6

illycaffè Hits Milestone with B Corp™ Recertification In an era where corporate responsibility isn't just fodder for feel-good presentations, illycaffè has proven it’s not just paying lip service to the idea. The Italian coffee titan has secured its B Corp™ recertification under snazzier, sharper V2 standards. This isn't just a shiny sticker to slap on marketing...

Continue Reading
Subaru, Motorq Offer Hardware-Free Fleet Telematics Insights

Updated Category News Views 6

An Unplugged Move in Fleet Management There's something brewing between Motorq and Subaru that could shake up fleet operations in ways most haven't thought possible yet. We’re talking about cutting those pesky hardware cords and diving straight into a future that's software-driven—and hey, we're all here for it. Direct, Data-Driven Leadership Imagine you're a fleet...

Continue Reading
Lincoln Educational Services Faces Securities Fraud Suit

Updated Category News Views 4

A Storm Brews Over Lincoln Educational Services You know, there's nothing quite like the stink of a good mess in the markets, and Lincoln Educational Services Corporation has found itself knee-deep in one. The buzz is all about some securities fraud allegations that could rope in a bunch of investors who got the short end of the stick. It’s lawsuits like these that make...

Continue Reading
New Podcast by Paralyzed Veterans of America Offers Unique Insights

Updated Category News Views 6

Empowering Veterans Through Storytelling Some stories don't just rattle around in your headphones—they stick with you. The 'Voices of PVA' podcast, launched by Paralyzed Veterans of America, aims to do exactly that. It's not just a podcast; it's a platform where voices of veterans and people with spinal cord injuries like MS and ALS aren't just heard, they're amplified....

Continue Reading

Top 5 Most Recently Viewed Articles

Key Insights into Precigen's Upcoming Earnings Event

Updated Category News Views 127

Overview of Precigen's Earnings Expectations Precigen (NASDAQ:PGEN) is gearing up for the release of its quarterly earnings report, creating a buzz among investors who are eagerly anticipating the company's performance. This quarterly update will provide crucial insights needed to navigate investment decisions in the coming weeks. Anticipated Earnings Market analysts are...

Continue Reading
Upcoming Housing Initiative Announcement: Join the Conversation

Updated Category News Views 136

Join Us for a Significant Housing Initiative Announcement In a proactive step towards addressing housing challenges, a notable announcement is set to occur soon. This event will feature key figures in government and infrastructure, spearheading discussions that are crucial for our communities. Engaging directly with the speakers will offer insight into the new initiatives...

Continue Reading
Viking Therapeutics Launches Phase 3 Study for VK2735

Updated Category News Views 446

Viking Therapeutics Unveils Phase 3 Clinical Program for VK2735 Viking Therapeutics, Inc. (NASDAQ: VKTX), a biopharmaceutical company invested in developing novel therapies, recently announced an exciting milestone: the initiation of its Phase 3 clinical program for VK2735, a dual agonist targeting the GLP-1 and GIP receptors. This innovative therapy is under evaluation...

Continue Reading
Chlorine Dioxide Market Growth Driven by Innovation and Demand

Updated Category News Views 139

Chlorine Dioxide Market Overview The Chlorine Dioxide Market is currently experiencing significant growth, primarily driven by increasing demands across key sectors such as water treatment, healthcare, food processing, and the pulp & paper industries. The growing focus on safe disinfection solutions and sustainability initiatives is leading to increased adoption of...

Continue Reading
MarketAxess Holdings' Upcoming Earnings Report Analysis

Updated Category News Views 129

Overview of MarketAxess Holdings' Earnings Report MarketAxess Holdings (NASDAQ: MKTX) is poised to release its latest quarterly earnings report soon. Investors are keen to understand the implications of this announcement, which promises insights into the company's performance and future guidance. Analyst Expectations Market analysts anticipate that the earnings per share...

Continue Reading